
Man, 26, with ‘never ending cough' diagnosed with ‘parrot chlamydia' after ‘accidentally' breathing in chicken poo
A YOUNG man was diagnosed with psittacosis - also known as 'parrot chlamydia' - after accidentally inhaling chicken poop.
The 26-year-old arrived at a hospital in China in January 2023, suffering from a cough that had lasted six days and a persistent high fever.
2
2
Doctors handling his case initially suspected the man from Zhejiang Province had a run-of-the-mill respiratory infection, but a chest scan revealed something more serious.
His lungs were filled with 'ground-glass opacities', a hazy pattern that usually shows up in people with viral pneumonia or Covid.
Despite treatment with standard antibiotics, his condition only got worse.
Tests on a lung sample found he had psittacosis - also called parrot fever - caused by chlamydia psittaci bacteria.
The chlamydia that causes psittacosis is not the same as the sexually transmitted chlamydia. They're just part of the same bacterial group.
It is a flu-like illness caused by contact with infected birds that can leave people suffering with severe pneumonia or brain and heart inflammation.
In this case, the man had been exposed to chicken poo prior to symptom onset.
"The patient kept more than 10 pigeons and had mistakenly inhaled chicken manure before symptom onset," the medics treating him wrote in the BMC Infectious Diseases.
Once diagnosed, his treatment was adjusted to include appropriate antibiotics, specifically: omadacycline and azithromycin.
Within two weeks his cough had "completely resolved" and a CT scan suggested his lungs were improving, the medics wrote.
Health alert after parrot fever that can trigger severe pneumonia and meningitis infects dozens of humans,
Austria, Denmark, Germany, Sweden and The Netherlands have all seen a sudden increase in parrot fever infections last year the World Health Organisation (WHO) previously warned.
"Psittacosis pneumonia should be considered in patients with the RHS and histories of contact with poultry or other birds," the authors concluded.
"The early diagnosis of the disease and proper adjustment of medication to reduce its severity are critical."
Symptoms of parrot fever tend to be mild and can resemble the flu, with sufferers experiencing fever and chills, headache, muscle aches and dry cough.
But left untreated, the illness can progress to severe pneumonia, inflammation of the heart called endocarditis, hepatitis and even brain swelling, according to the Centers for Disease Control and Prevention (CDC).
Prompt antibiotic treatment is needed to avoid complications from psittacosis, the World Health Organisation says.
What are the symptoms of psittacosis?
PSITTACOSIS is a respiratory infection caused by the bacteria Chlamydophila psittaci found in birds.
Most people begin developing signs and symptoms within five to 14 days after exposure to the bacteria, according to the Wold Health Organisation.
Prompt antibiotic treatment is effective and can help avoiding complications such as pneumonia.
With appropriate antibiotic treatment, psittacosis rarely results in death, with less than one in 100 cases being fatal.
Symptoms of parrot fever include:
Fever and chills
Headache
Muscle aches
Dry cough
Though most people treated for parrot fever make a full recovery, some have serious complications and need hospital care.
These include:
Pneumonia (lung infection)
Endocarditis (inflammation of the heart valves)
Hepatitis (inflammation of the liver)
Inflammation of the nerves or the brain, leading to neurologic problems
Symptoms of psittacosis are similar to many other respiratory illnesses and tests to detect the bacteria directly may not be readily available.
For these reasons, doctors may not suspect it, making psittacosis difficult to diagnose.
You should tell your GP if you get sick after buying or handling a pet bird or poultry.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
7 hours ago
- Daily Mail
Statins almost halve the risk of death in patients critically ill with sepsis
Taking statins can improve the chances of surviving sepsis by 40 per cent, a trial has found. Sepsis can occur when the body's immune system overreacts to an infection and attacks its own organs. It is notoriously difficult to spot because the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins lower cholesterol to prevent heart attacks and strokes and are taken by around 5 million adults in the UK. But experts say they have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent (file image) In intensive care, 14.3 per cent of 6,000 sepsis patients given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. For those no longer in a critical condition, 11 per cent given statins died compared to 19 per cent who were not. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Researchers believe the drugs may help with sepsis by helping to combat bacteria directly, reducing the toll infection takes on the body. Earlier this year another study found the pills could also slash dementia risk – even in patients who don't have high cholesterol. The sepsis study, published in the journal Frontiers in Immunology, was based on data from thousands of patients at an Israeli hospital over a decade. Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'This study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Sepsis is known as the 'silent killer'. For every hour of delay in treatment, a patient's chance of dying increases 8 per cent. If caught early, it can be treated with antibiotics and fluids. Symptoms include slurred speech or confusion, shivering or muscle pain, passing no urine in a day, severe breathlessness and mottled or discoloured skin. Blood test to spot Alzheimer's early A Blood test for Alzheimer's can accurately detect the disease early, a study suggests. The test was 95 per cent accurate in identifying people with memory problems. It also scored 82 per cent for specificity, which means it was highly accurate in ruling out people without dementia. The study, published in the journal Alzheimer's and Dementia, found proteins amyloid beta 42/40 and p-tau217 in blood plasma can be examined to diagnose the condition. The study was carried out on more than 500 people in an outpatient memory clinic. The blood test has already been approved by the Food and Drug Administration regulator in the US.


The Independent
10 hours ago
- The Independent
New coronavirus discovered in China ‘only small step' from infecting humans
A new coronavirus discovered in China is only a small step from mutating and causing another global pandemic, experts have warned. Scientists believe the variant, called HKU5-CoV-2, may infect a broader range of animals than Covid-19 – which caused millions of deaths – and may have more potential for jumping between species. US researchers fear that HKU5-CoV-2, found in China, in February, could also infect humans, leading to a widespread outbreak. The new study, published in Nature Communications, looked at a lesser-known group of coronaviruses called merbecoviruses, which includes HKU5 and MERS-CoV, which is responsible for the deadly Middle East Respiratory Syndrome. The team from Washington State University looked at how the new pathogen interacts with human cells. They found that a small change in the virus's spike protein could allow it to attach to human ACE2 cells in people's throats, mouths and noses. HKU5-CoV-2 can infect and replicate inside human cells in both the airways and gut. According to the World Health Organisation, about 35 per cent of people infected with Middle East Respiratory Syndrome die. Since 2012, some 27 countries have reported cases, leading to 858 known deaths due to the infection, which spread from camels. But when HKU5 was discovered in February, scientists warned against exaggerating the risks because it does not enter human cells as readily as Sars-CoV-2, which caused Covid-19. HKU5 was first detected in bats by scientists from the Chinese laboratory where some say Covid originated in 2019. Prof Michael Letko, a virologist who co-led the study, said: 'HKU5 viruses in particular really hadn't been looked at much, but our study shows how these viruses infect cells. 'What we also found is HKU5 viruses may be only a small step away from being able to spill over into humans.' When Covid-19 emerged it was widely blamed on markets in China where different breeds of wild animal are kept caged and often slaughtered close to other animals. Meat is sold at the open-air stalls. Critics said the markets were the perfect breeding ground for new zoonotic diseases – those that spread to humans – to emerge. The scientists, whose experiments studied how the new pathogen interacts with human cells, believe the virus would have to carry certain mutations if it were to infect humans. 'These viruses are closely related to MERS, so we have to be concerned if they ever infect humans,' Prof Letko said. 'While there's no evidence they've crossed into people yet, the potential is there and that makes them worth watching.'


The Independent
19 hours ago
- The Independent
Critically ill patients with sepsis more likely to survive when given statins
Research indicates that critically ill sepsis patients who receive statins may have a higher chance of survival. A study of 6,000 sepsis patients given statins showed 14.3 per cent died within 28 days, compared to 23.4 per cent of 6,000 patients who did not receive statins, equating to a 39% reduced risk of death. The study, conducted using data from a hospital in Israel between 2008 and 2019, also found lower mortality rates in intensive care and overall hospital stays for statin users. Dr. Caifeng Li, the study's corresponding author, suggested that statins may offer a protective effect and improve outcomes for sepsis patients. Dr. Ron Daniels, founder and chief executive of the UK Sepsis Trust, supports calls for larger trials to confirm the findings, noting the potential survival benefit from the anti-inflammatory properties of statins.